Advertisement
Screener

Aligos Therapeutics, Inc. (ALGS) Pre-Tax Margin

Aligos Therapeutics, Inc. (ALGS) Pre-Tax Margin

  • 2026-03-31: Pre-Tax Margin -802.93%.
  • 2025-12-31: Pre-Tax Margin -11746.15%.
  • 2025-09-30: Pre-Tax Margin -4248.45%.
  • 2025-06-30: Pre-Tax Margin -1624.66%.

Complete source-backed pre-tax margin history.

Available history
2023-03-31 to 2026-03-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-03-31-802.93%
2025-12-31-11746.15%
2025-09-30-4248.45%
2025-06-30-1624.66%
2025-03-3113868.49%
2024-12-31-13551.65%
2024-09-30-1533.44%
2024-06-30494.82%
2024-03-31-5020.03%
2023-12-31-4155.06%
2023-09-30-1660.09%
2023-06-30-419.98%
2023-03-31-16368.57%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-1092.36%
2024-12-31-3624.48%
2023-12-31-1403.39%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Alector, Inc. (ALEC)United States$0.213B-1.90
Invivyd, Inc. (IVVD)United States$0.270B-2.42
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22